It means that the committee can now accept evidence generated by the tool as scientifically valid in future applications and assessments for new MASH treatments. MASH is a condition linked with ...

tool called AIM-NASH in clinical trials to help identify the severity of a type of fatty liver disease. The condition, called metabolic dysfunction-associated steatohepatitis, or MASH, is a ...